We report a prospective, nationwide cohort evaluating the safety and effectiveness of CT-P13
PROSIT Investigators. The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy / Alessandro Armuzzi, G.F.. - In: INFLAMMATORY BOWEL DISEASES. - ISSN 1078-0998. - ELETTRONICO. - 25:(2019), pp. 568-579. [10.1093/ibd/izy264]
PROSIT Investigators. The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy
Natalia Manetti;Paolo Lionetti;
2019
Abstract
We report a prospective, nationwide cohort evaluating the safety and effectiveness of CT-P13
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
prosit IBD 2019.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
1.15 MB
Formato
Adobe PDF
|
1.15 MB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
